7.7
[]. D H Peters, et al. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs. 994 Jun;47(6):00-32.
[2]. T Arima, et al. Comparison of effects of tiapride and sulpiride on D-, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes. Jpn J Pharmacol. 96 Jul;4(3):49-23.
[3]. Andreia Teixeira-Castro, et al. Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain. 20 Nov;3(Pt ):322-37.
[4]. C Cohen, et al. Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride. J Pharmacol Exp Ther. 997 Nov;23(2):66-73.
[]. C Eggers, et al. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci. 9;237(4):223-9.
H302-H3-H39-H33
P26-P264-P270-P27-P20-P302+P32-P304+P340-P30+P3+P33-P330-P362+P364-P403+P233-P40-P0